Document is current
Any future updates will be listed below
-
Authors
Williams, Katie B.
Horst, Michael
Young, Millie
Pascua, Christine
Puffenberger, Erik G.
Brigatti, Karlla W.
Gonzaga-Jauregui, Claudia
Shuldiner, Alan R.
Gidding, Samuel
Strauss, Kevin A.
Chowdhury, Devyani
- License Information
-
More Information
Article History
Received: 3 November 2021
Accepted: 17 February 2022
First Online: 17 March 2022
Declarations
:
: The Institutional Review Board of Penn Medicine-Lancaster General Hospital (Lancaster, PA) approved the research study. Written informed consent was obtained from study participants age 18 years and older to participate in the research study. Written informed consent was obtained from parents on behalf of their children age less than 18 years to participate in the research study. Study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: SG serves as a consultant for Esperion Therapeutics, Inc. and as part of the advisory board for Silence Therapeutics. ARS and CGJ are employees of Regeneron Pharmaceuticals, Inc. and receive compensation in the form of salary and stock incentives for their employment. Remaining authors have no declarations of interest.
